Dexrazoxane enhances efficacy of all-trans retinoic acid in acute myeloid leukemia patient blast cells and cell lines-Reference-Cited by-同舟云学术

Dexrazoxane enhances efficacy of all-trans retinoic acid in acute myeloid leukemia patient blast cells and cell lines

Published:2020-10-16 Issue:2 Volume:62 Page:473-477
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Norris Eric J.¹^ORCID,Patel Yogin C.¹,Klotz Kaitlin E.¹,Steuerwald Nury²,Jones Wendell D.³^ORCID,Maciejewski Jaroslaw P.⁴^ORCID,Ganapathi Ram N.¹^ORCID,Ganapathi Mahrukh K.¹^ORCID

Affiliation:

1. Department of Cancer Pharmacology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA

2. Molecular Biology and Genomics Core Facility, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA

3. EA Genomics, Division of Q Solutions, Morrisville, NC, USA

4. Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1827245

Reference15 articles.

1. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML

2. Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

3. Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B

4. The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA

5. Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells